According to the research report titled, ‘Global Home Infusion Therapy Devices Market Size study, by By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy) and Regional Forecasts 2021-2027,’ available with MarketStudyReport, global home infusion therapy devices market was valued at USD 18.3 billion in 2020 and is anticipated to register an annual growth rate of 8.5% during 2021-2027, thereby accumulating USD 32.39 billion by the end of the forecast duration.
 

Escalating demand for the product and cost effectiveness of the associated therapy are majorly aiding towards the expansion of global home infusion therapy devices market. Rapid technological advancements in this business field is also adding momentum to market progression.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4285170/
 

For the unversed, home infusion therapy involves the administration of medication for diseases such as cancer in a patient’s home. As per World Health Organization, around 19.3 million new cancer cases were registered worldwide in 2020 alone.
 

In addition, surging geriatric population, growing preference towards using home care, and rising prevalence of hospital-acquired infections are augmenting industry outlook. Besides, the outbreak of the COVID-19 has also increased the demand for home infusion therapy to reduce the risk of infection.
 

On the contrary, rigid government regulations associated with the manufacturing of these devices is likely to hamper the remuneration scope of global home infusion therapy devices market in the ensuing years.
 

Regionally speaking, North America, Europe, Latin America, and Asia Pacific are considered to understand the dynamics of this business sphere. North America presently holds a significant market share owing to growing adoption of latest technology in infusion pumps.
 

Meanwhile, Asia Pacific market also likely to generate lucrative revenues during 2021-2027 accreditable to increasing cognizance about the advantages of home infusion therapy over hospitals.
 

Caesarea Medical Electronics Ltd., Becton, Dickinson and Company, ICU Medical Inc.,  Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, PharMerica Corporation, BriovaRx LLC, Diplomat (Optum Inc.), Option Care Enterprises Inc., and Coram CVS are the leading players defining the competitive hierarchy of global home infusion therapy devices market.
 

The abovementioned players are taking strategic decisions like mergers & acquisitions, new product launches, R&D investments, partnerships, and collaboration deals to strengthen their position in the overall market and garner substantial returns.